IP Library Granted Patent US 9,649,408
Granted Patent B1
US 9,649,408 · App. 12/939,629 · Granted May 16, 2017

Systems and methods for sterilization of bone or bone components

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,649,408
App. No.
12/939,629
Granted
May 16, 2017
Kind
B1
Abstract

Systems for sterilization of demineralized bone matrices are provided.

Claims (22)

1. A method for sterilizing demineralized bone matrix, comprising:

packaging the demineralized bone matrix in an inner package prior to treatment with super critical CO 2 , the inner package being permeable to super critical CO 2 and a sterilant,

packaging the inner package in an outer package prior to treatment with super critical CO 2 , the outer package comprising (i) a first portion including a material that is permeable to super critical CO 2 and the sterilant, and (ii) a second portion that is impermeable to moisture,

treating the demineralized bone matrix with super critical CO 2 and the sterilant to sterilize the demineralized bone matrix, and

sealing the first portion of the outer package with the second portion of the outer package subsequent to sterilization such that the inner package is sealed within a moisture impermeable enclosure,

wherein the demineralized bone matrix maintains osteoinductivity after sterilization and storage at ambient temperature for at least 12 months.

2. The method of claim 1 , wherein the sterilant comprises peracetic acid (PAA).

3. The method of claim 2 , wherein the sterilant further comprises a peroxide.

4. The method of claim 3 , wherein the peroxide is H 2 O 2 .

5. The method of claim 4 , wherein concentrations of PAA and H 2 O 2 in the sterilant are 10-14% and 1-3%, respectively.

6. The method of claim 4 , further comprising treating the demineralized bone matrix in a chamber, wherein concentrations of PAA and H 2 O 2 in the chamber are 1-1000 ppm and 1-1000 ppm, respectively.

7. The method of claim 6 , wherein the concentrations of PAA and H 2 O 2 in the chamber are 20-100 ppm and 1-10 ppm, respectively.

8. The method of claim 1 , wherein the demineralized bone matrix is sterilized when mixed with other materials.

9. The method of claim 1 , wherein during the sterilization process, pressure and temperature are kept constant.

10. The method of claim 1 , wherein after treatment with super critical CO 2 , the demineralized bone matrix is placed in a nitrogen atmosphere for 0-24 hours.

11. The method of claim 1 , further comprising mixing the demineralized bone matrix with a particulate acellular tissue matrix before or after sterilization.

12. A method for sterilizing demineralized bone matrix, comprising:

packaging the demineralized bone matrix in an inner package prior to treatment with super critical CO 2 , the inner package being permeable to super critical CO 2 and a sterilant,

packaging the inner package in an outer package prior to treatment with super critical CO 2 , the outer package comprising (i) a first portion including a material that is permeable to super critical CO 2 and the sterilant, and (ii) a second portion that is impermeable to moisture,

treating the demineralized bone matrix with super critical CO 2 and the sterilant to sterilize the demineralized bone matrix,

after treatment with super critical CO 2 and the sterilant, placing the demineralized bone matrix in a nitrogen atmosphere for 24 hours, and

sealing the first portion of the outer package with the second portion of the outer package subsequent to sterilization such that the inner package is sealed within a moisture impermeable enclosure.

Assignments (9)
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST Recorded Feb 1, 2017
From: BANK OF AMERICA, N.A.
To: LIFECELL CORPORATION
Reel/Frame 041143/0361 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2015
From: QIU, QING-QING; CONNOR, JEROME
To: LIFECELL CORPORATION
Reel/Frame 037026/0135 →